Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 10.50
0.00 (0.00%)
At close: Feb 12, 2026
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 112.14 million as of February 12, 2026. Its market cap has increased by 431.08% in one year.
Market Cap
112.14M
Enterprise Value
123.99M
Revenue
30.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
Market Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 112.14M, a decrease of -33.95%. That is a compound annual growth rate of -4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 112.14M | 7.22% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 36.19B |
| Hikma Pharmaceuticals | 3.44B |
| HUTCHMED (China) | 1.88B |
| Allergy Therapeutics | 718.55M |
| Animalcare Group | 194.71M |
| Venture Life Group | 87.37M |
| ECO Animal Health Group | 73.18M |
| Provexis | 35.07M |